EAU Real Life Data Registry on ProACT? and ACT

Why this Real Life Data Registry?
This project aims at providing clinical outcome data from real-life practice for the clinical and scientific community, regulatory agencies as well as patient groups on the use of Adjustable Continence Therapy, a novel technology in the treatment of female stress urinary incontinence (ACT) and male stress urinary incontinence (ProACT) after radical prostatectomy and TURP.

The research programme is a joint venture between the EAU Research Office (EAU-RO), Uromedica and Medtronic. Uromedica and Medtronic have identified the need for a prospective, real-life, open-source, data registry on ProACT and ACT systems in Europe. 

For more info, please click here or to apply, please send an email to ACT or ProACT.